Stocktoria

Phreesia, Inc. PHR

NYSE · stock · Services-Business Services, NEC · website · IPO 2019-07-18 · LEI

Phreesia, Inc. (PHR) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2026 revenue was $480.6M at a 0.5% net margin.

Chart by TradingView
37/100
Stocktoria Quality Score · grade D
5/9
Piotroski F — financial health
-1.95
Altman Z″ — distress risk · distress
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 5 3 3 3 6 5 2020202120222023202420252026
Altman Z″
-0.63 5.09 5.47 -1.62 -5.28 -3.98 -1.95 2020202120222023202420252026

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$12.26 as of 2026-08-01 · -61.3% 1y
$8.38$31.6652-wk
Market cap USD$622M
P / E269.9×
Net margin 5y avg-34%
Return on equity 5y avg-33.1%
Beta0.88
Employees1,789

Analyst price target

$13.94 +13.7% vs last
consensus: buy · 17 analysts
target range $9.00 – $20.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net sold -$28,078 on the open market · 2 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 8y · up

How it ranks in Services · percentile among 982 companies

Piotroski Fstronger than 54%
Net marginstronger than 53%
Return on equitystronger than 50%
Revenue growthstronger than 69%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.146
Retained earnings / assets-1.204
EBIT / assets-0.01
Equity / liabilities1.033

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
PHRPhreesia, Inc.5/9-1.95269.9+14.5%
LQDTLIQUIDITY SERVICES INC6/93.3143.4+31.2%
EEXEmerald Holding, Inc.4/9-1.59+16.2%
UXINUxin Ltd3/9+143.3%
SEZLSezzle Inc.7/98.0443.1+66.1%
FVRRFiverr International Ltd.7/9219.1+10.1%
ICTSFICTS INTERNATIONAL N V2/90.59+10.6%

All Services companies →

About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

FAQ

Is PHR financially healthy?

Phreesia, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does PHR pay a dividend?

No, Phreesia, Inc. does not currently pay a dividend.

How profitable is PHR?

In FY2026, Phreesia, Inc. had a net margin of 0.5% and a return on equity of 0.7%.

What is PHR's P/E ratio?

Phreesia, Inc.'s trailing price-to-earnings (P/E) ratio is about 269.9×, based on its latest annual earnings.

What is the analyst price target for PHR?

The average Wall-Street price target for Phreesia, Inc. is $13.94, about 13.7% above the recent price, from 17 analysts (consensus: buy).

Is PHR a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Phreesia, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 269.9×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.